DOMIDEP acquired by I SQUARED CAPITAL, UI INVESTISSEMENT & BNP PARIBAS DEVELOPPEMENT
Context
I-Squared Capital entered into a binding agreement to acquire a majority stake in Domidep from its founder and a consortium of minority financial investors (UI Gestion, BNP Paribas Developpement, Bpifrance, and Carvest). This acquisition serves as a cornerstone for the acquirer's European healthcare strategy, with a focus on institutionalizing the group's operations and funding further international expansion into markets such as Germany and Belgium. The deal was supported by a significant senior secured term loan of over EUR400 million, along with equity injections from the new sponsor.
DOMIDEP, which reported an EBITDA margin of LOGIN in 2019, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded in 1989, Domidep is the fifth-largest private operator of elderly care homes in France. Headquartered in L'Isle-d'Abeau, the group manages a network of approximately 100 specialized facilities, providing residential care, medical assistance, and dependency services to nearly 7,000 residents. The company stands out as a "pure player" in the French long-term care market, emphasizing local culture by allowing each residence to maintain its own unique name rather than a corporate brand.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Similar deals in Healthcare & Pharma
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 01/2020 | VIVALTO SANTÉ | MATHILDE MÉDICAL DÉVELOPPEMENT | FRANCE | Health Providers | Vivalto Santé acquired Mathilde Médical Développement, adding four establishments — two clinics and two radiotherapy centres — to its existing Normandie footprint. The acquisition complements Vivalto Santé's existing presence in the region through the Clinique de l'Europe in Rouen and the Hôpital Pasteur in Evreux. The deal follows a series of acquisitions completed in 2019, including the Hôpital Privé du Confluent in Nantes, the Polyclinique de l'Europe in Saint-Nazaire, and the Polyclinique du Parc in Cholet, reflecting Vivalto Santé's ongoing buy-and-build strategy across the French private hospital market |
| 12/2019 | CIRCLE HEALTH | BMI HEALTHCARE | UNITED KINGDOM | Health Providers | : Circle Health Holdings acquired 100% of GHG Healthcare Holdings Limited, the indirect parent of BMI Healthcare, creating a combined private hospital group operating 55 hospitals and clinics across the UK. The transaction was reviewed by the UK Competition and Markets Authority (CMA), which identified competition concerns in two local markets — Bath (where the Parties were the two largest PHMS providers and competed closely) and Birmingham (where Circle's planned new hospital would have competed directly with BMI's two existing facilities) |
| 07/2019 | NAXICAP PARTNERS / ARDIAN | EMERA | FRANCE | Health Providers | Naxicap Partners entered into exclusive negotiations to acquire a majority stake in Emera. The transaction was highly competitive, involving bidders from both strategic industrial backgrounds and infrastructure funds. To secure the deal, the acquirer formed a partnership with one of its primary subscribers to cover the equity requirement for the "upper mid-cap" valuation. The founding family and the management team significantly reinvested in the operation, with the founder of a major industry peer also joining the round as a strategic minority partner |
| 07/2019 | TRITON PARTNERS | ALERIS | SWEDEN | Health Providers | Triton Partners acquired a controlling majority stake in Aleris Group from Patricia Industries in a significant Nordic healthcare transaction. The deal was structured via a definitive share purchase agreement and funded primarily through equity drawn from the Triton Fund V, a flagship vehicle that finalized fundraising at €5 billion in January 2019. Under the binding terms of the carve-out agreement, the digital healthcare platform entity Doktor24 was explicitly excluded from the perimeter and remained under the ownership of Patricia Industries |
| 04/2019 | COLISÉE | ARMONEA | BELGIUM | Health Providers | Colisée Group entered into a definitive agreement to acquire 100% of Armonea to create the fourth-largest elderly care operator in Europe. This transformative acquisition doubled Colisée’s size, resulting in a combined entity with a turnover of approximately €1 billion and a network of 270 facilities across five countries. The merger was strategically designed to capitalize on geographic complementarities, merging Colisée’s strong Mediterranean presence with Armonea’s market leadership in Northern Europe |
| 03/2019 | DOMUSVI | RESIDALYA | FRANCE | Health Providers | DomusVi entered into exclusive negotiations to acquire 100% of the capital of Residalya, in a move designed to significantly densify its territorial coverage within France. The transaction allowed DomusVi to absorb 35 additional facilities and roughly 2,630 beds, bringing its total capacity to over 17,000 beds and narrowing the gap with its primary market competitors. This strategic build-up was motivated by the need to reach a critical industrial scale, merging Residalya’s localized expertise and specialized assets—including the ownership of twelve of its residences—into DomusVi’s global operational platform |
| 01/2019 | HUMANA | CORONARIA HOIVA | FINLAND | Health Providers | Humana AB entered into a definitive agreement to acquire 100% of Coronaria Hoiva Oy to significantly expand its operational footprint in the Finnish market. This strategic acquisition was designed to integrate Coronaria Hoiva’s specialized residential care portfolio into Humana’s existing Finnish operations, creating a more diversified and robust platform for social care delivery. The transaction was financed through a combination of existing cash reserves and new credit facilities, and it received formal approval from the Finnish Competition and Consumer Authority in early April |
| 04/2018 | INVESTINDUSTRIAL | LIFEBRAIN | ITALY | Health Providers | Investindustrial acquired a controlling stake in Lifebrain from the investment vehicle lb EK Management. The deal follows a period of intense growth supported by MCI Capital, during which the group established itself as a leading consolidator in the fragmented Italian laboratory market. The acquisition was structured through a Luxembourg vehicle, European Laboratory Services, and aimed to provide the capital and expertise necessary to professionalize the group and accelerate its aggressive acquisition strategy across Italy |
| 03/2018 | ICV PARTNERS | OUTPATIENT IMAGING AFFILIATES | UNITED STATES | Health Providers | ICV Partners has acquired Outpatient Imaging Affiliates (OIA) from its founder, Frank Kyle, and MedCare Investment Funds, a family office. This acquisition represents a platform investment for ICV in the outpatient imaging sector. The firm identified OIA as a well-positioned player due to its partnership-based model with hospital systems, operational expertise, and successful track record of integrating new imaging centers. Given the highly fragmented nature of the US outpatient imaging market, ICV saw this transaction as an opportunity to pursue an active external growth strategy while continuing to drive organic growth |
| 03/2018 | THE ADOLFSEN GROUP | FRÖSUNDA | SWEDEN | Health Providers | Pan-European private equity firm Hg has successfully completed the divestiture of its majority equity stake in Swedish care provider Frösunda Omsorg AB to Norway-based investment firm The Adolfsen Group. Executed through the holding company Brado—an investment vehicle owned by brothers Kristian and Roger Adolfsen—the transaction concludes a highly successful eight-year holding period for the sponsor. Throughout the targeted sale process, Hg was exclusively advised by investment bank Carnegie, acting as sole financial advisor |
REFERENCES
Valuation range: EV 1b - 4b EUR
Revenue range: 250M - 500M EUR
EBITDA range: 50M - 100M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DOMIDEP by I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENT are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Acquirer: i squared capital / ui investissement / bnp paribas developpement